April 10, 2011Open Access

A Multicenter Study of -2Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

Key Points

Key points are not available for this paper at this time.

Abstract

The prostate health index may be useful in prostate cancer screening to decrease unnecessary biopsy in men 50 years old or older with prostate specific antigen 2 to 10 ng/ml and negative digital rectal examination with minimal loss in sensitivity.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Catàlona et al. (Sun,) studied this question.

synapsesocial.com/papers/69de9d455e582bd3c5e93ea8 https://doi.org/https://doi.org/10.1016/j.juro.2010.12.032

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control2008 · 955 citations
2The Statistical Evaluation of Medical Tests for Classification and Prediction2005 · 1,922 citations
3The Jackknife, the Bootstrap and Other Resampling Plans1982 · 8,004 citations
4Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features2002 · 170 citations
5Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach1988 · 22,327 citations

Bookmark

View Full Paper